Compare CHMG & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHMG | TKNO |
|---|---|---|
| Founded | 1833 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.1M | 308.3M |
| IPO Year | 1995 | 2021 |
| Metric | CHMG | TKNO |
|---|---|---|
| Price | $81.13 | $5.03 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $57.00 | N/A |
| AVG Volume (30 Days) | 53.3K | ★ 137.9K |
| Earning Date | 04-17-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.04% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 1.91 | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $37.32 | $8.27 |
| Revenue Next Year | $9.13 | $13.13 |
| P/E Ratio | $39.04 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $48.61 | $1.91 |
| 52 Week High | $78.42 | $6.68 |
| Indicator | CHMG | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 68.15 | 45.14 |
| Support Level | $68.15 | $5.00 |
| Resistance Level | N/A | $5.88 |
| Average True Range (ATR) | 2.81 | 0.38 |
| MACD | 0.10 | -0.08 |
| Stochastic Oscillator | 99.89 | 23.33 |
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.